These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22278598)

  • 1. Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.
    Rasmussen AL; Tchitchek N; Susnow NJ; Krasnoselsky AL; Diamond DL; Yeh MM; Proll SC; Korth MJ; Walters KA; Lederer S; Larson AM; Carithers RL; Benecke A; Katze MG
    Hepatology; 2012 Jul; 56(1):17-27. PubMed ID: 22278598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant: A real-life experience.
    Araujo A; Valenzuela-Granados V; Lopes AB; Michalczuk MT; Mantovani A; Alvares-da-Silva MR
    Ann Hepatol; 2019; 18(3):450-455. PubMed ID: 31028014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of hepatitis C virus reinfection after liver transplantation.
    Powers KA; Ribeiro RM; Patel K; Pianko S; Nyberg L; Pockros P; Conrad AJ; McHutchison J; Perelson AS
    Liver Transpl; 2006 Feb; 12(2):207-16. PubMed ID: 16447184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To transplant or not to transplant recurrent hepatitis C and liver failure.
    Forman LM
    Clin Liver Dis; 2003 Aug; 7(3):615-29. PubMed ID: 14509530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative viral kinetics: new insights or the Emperor's new clothes?
    Charlton M
    Liver Transpl; 2006 Feb; 12(2):194-5. PubMed ID: 16447194
    [No Abstract]   [Full Text] [Related]  

  • 7. Allograft TNFbeta and IL16 polymorphisms influence HCV recurrence and severity after liver transplantation.
    Kimball P; Baker M; Fisher RA
    Liver Transpl; 2006 Feb; 12(2):247-52. PubMed ID: 16447204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
    Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
    Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology methods help develop a better understanding of hepatitis C virus-induced liver injury.
    Singaravelu R; Nasheri N; Sherratt A; Pezacki JP
    Hepatology; 2012 Jul; 56(1):1-4. PubMed ID: 22430896
    [No Abstract]   [Full Text] [Related]  

  • 10. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C.
    Rayhill SC; Kirby PA; Voigt MD; La Brecque DR; Lutz CT; Katz DA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Heisey D; Wu YM; Schmidt WN
    Transplantation; 2005 Aug; 80(4):448-56. PubMed ID: 16123717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.
    Diamond DL; Krasnoselsky AL; Burnum KE; Monroe ME; Webb-Robertson BJ; McDermott JE; Yeh MM; Dzib JF; Susnow N; Strom S; Proll SC; Belisle SE; Purdy DE; Rasmussen AL; Walters KA; Jacobs JM; Gritsenko MA; Camp DG; Bhattacharya R; Perkins JD; Carithers RL; Liou IW; Larson AM; Benecke A; Waters KM; Smith RD; Katze MG
    Hepatology; 2012 Jul; 56(1):28-38. PubMed ID: 22331615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hepatitis C virus infection and its recurrence after liver transplantation on functional performance and health-related quality of life.
    Feurer ID; Wright JK; Payne JL; Kain AC; Wise PE; Hale P; Chapman WC; Speroff T; Pinson CW
    J Gastrointest Surg; 2002; 6(1):108-15. PubMed ID: 11986026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and liver transplantation.
    Ahmed A; Keeffe EB
    Clin Liver Dis; 2001 Nov; 5(4):1073-90. PubMed ID: 11685796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus in the transplant setting.
    Berenguer M; Wright TL
    Antivir Ther; 1998; 3(Suppl 3):125-36. PubMed ID: 10726062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.
    Minisini R; Giarda P; Grossi G; Bitetto D; Toniutto P; Falleti E; Avellini C; Occhino G; Fabris C; Pirisi M
    J Gastroenterol; 2011 Nov; 46(11):1307-15. PubMed ID: 21789480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
    Klintmalm GB; Davis GL; Teperman L; Netto GJ; Washburn K; Rudich SM; Pomfret EA; Vargas HE; Brown R; Eckhoff D; Pruett TL; Roberts J; Mulligan DC; Charlton MR; Heffron TG; Ham JM; Douglas DD; Sher L; Baliga PK; Kinkhabwala M; Koneru B; Abecassis M; Millis M; Jennings LW; Fasola CG
    Liver Transpl; 2011 Dec; 17(12):1394-403. PubMed ID: 21850690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.